Market Movers (8-K)
See all →NYSE
Macy's, Inc. announced robust first-quarter 2026 results, exceeding expectations with 3.0% comparable sales growth and raising its full-year financial guidance.
Better than expected
NYSE
Macy's, Inc. shareholders approved the Amended and Restated 2024 Equity and Incentive Compensation Plan and elected ten directors at the annual meeting on May 15, 2026.
NYSE
Macy's Inc. announced three directors will not seek re-election, reducing its Board of Directors from 13 to ten members to enhance efficiency and align with strategic focus.
NYSE
Macy's, Inc. reported strong fourth-quarter and fiscal year 2025 results, exceeding guidance with a return to positive comparable sales growth and increased shareholder returns.
Better than expected
NYSE
Macy's, Inc. announced its Board of Directors has scheduled the annual meeting of stockholders for May 15, 2026, with a record date of March 19, 2026.
NYSE
Macy's Inc. announced a $2.7 million cash payment to former Chief Operating Officer and Chief Financial Officer Adrian V. Mitchell to finalize his separation compensation.
Quarterly Earnings (10-Q)
See all →NYSE
Macy's reported strong first-quarter 2026 results with a 3.0% increase in comparable sales and growth across all three retail nameplates.
Better than expected
NYSE
Macy's, Inc. reported a significant decline in net income and diluted EPS for Q3 and the first 39 weeks of 2025, despite positive comparable sales growth driven by its 'Bold New Chapter' strategy.
Worse than expected
Capital raise
NYSE
Macy's, Inc. filed an amendment to its quarterly report for the period ended August 2, 2025, solely to correct the Chief Financial Officer's name in the required certifications.
NYSE
Macy's, Inc. reports a significant drop in second-quarter net income and diluted EPS, despite comparable sales growth in its go-forward businesses and luxury brands.
Capital raise
Worse than expected
NYSE
Macy's, Inc. reported a significant decline in net sales, operating income, and net income for the first quarter of 2025, primarily due to the closure of underperforming stores and reduced international tourism, despite positive comparable sales growth in its luxury and beauty segments.
Worse than expected
NYSE
Macy's, Inc, reports third-quarter results marked by strategic progress, accounting revisions, and varied performance across its nameplates.
Worse than expected
Annual Reports (10-K)
NYSE
Macy's, Inc. reports a 1.5% comparable sales increase for 2025, driven by its "Bold New Chapter" strategy, despite a 2.4% decline in net sales due to store closures.
Capital raise
NYSE
Macy's, Inc. reports its fiscal year 2024 performance, highlighting progress on its 'A Bold New Chapter' strategy focused on enhancing the omni-channel experience and reallocating capital.
Worse than expected
NYSE
10-K: Macy's Navigates Strategic Shift Amidst Declining Sales: A Deep Dive into the 2024 10-K Filing
Macy's 2024 10-K filing reveals a company in transition, outlining a new strategic plan, 'A Bold New Chapter,' to address declining sales and enhance shareholder value through store rationalization, luxury growth, and operational modernization.
Worse than expected
Insider Trading (Form 4)
See all →NYSE
Richard L. Markee, a Director at Macy's, Inc., reported the conversion of 1,322 phantom stock units into common stock on June 30, 2026.
NYSE
Form 4: Macy's SVP Sells Shares
Macy's SVP and Controller Paul Griscom reported a sale of 10,077 shares of common stock.
NYSE
Macy's EVP, COO & CFO Thomas Edwards Jr. reported a transaction involving the sale of shares to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
Director Paul C. Varga was granted 8,348 restricted stock units as part of his compensation package with Macy's, Inc.
NYSE
Director Richard L. Markee was granted 8,348 restricted stock units as part of his compensation for service on the Macy's, Inc. Board of Directors.
NYSE
Macy's, Inc. director Jill Granoff was granted 8,348 restricted stock units as part of standard board compensation.
Proxy Statements (Def-14A)
See all →NYSE
Macy's Inc. will hold its annual shareholder meeting virtually on May 16, 2025, with voting open until May 15, 2025.
NYSE
Macy's proxy statement highlights the company's 'Bold New Chapter' strategy, board member elections, executive compensation, and the addition of Robert Chavez to the Board.
NYSE
Macy's, Inc. is soliciting proxies for its upcoming Annual Meeting of Shareholders on May 17, 2024, covering key items including director elections, auditor ratification, executive compensation, and a new equity incentive plan.
NYSE
Macy's, Inc. nominates Douglas W. Sesler, Founder and President of Fair Street Partners, to its Board of Directors to enhance real estate expertise, while Francis S. Blake will not stand for reelection.
NYSE
Macy's has filed a preliminary proxy statement detailing the upcoming Annual Meeting of Shareholders and ongoing discussions with Arkhouse and Brigade, while also announcing Doug Sesler as a nominee for the Board of Directors.
NYSE
DEFA14A: Macy's Confirms Receipt of Revised Acquisition Proposal from Arkhouse and Brigade at $24 Per Share
Macy's has received a revised, unsolicited, non-binding proposal from Arkhouse and Brigade to acquire all outstanding shares for $24.00 per share in cash and will evaluate the offer.
Schedule 13G - Passive Investments
See all →NYSE
SCHEDULE: Vanguard Discloses Macy's Stake
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 4.94% of Macy's Inc. common stock as of June 30, 2026.
NYSE
SCHEDULE: Vanguard Reports 4.96% Stake in Macy's
Vanguard Capital Management disclosed a beneficial ownership of 4.96% of Macy's Inc. common stock as of June 30, 2026.
NYSE
SCHEDULE: Vanguard Discloses 5.07% Stake in Macy's
Vanguard Capital Management has reported beneficial ownership of over 13.3 million shares, representing 5.07% of Macy's Inc. common stock as of March 31, 2026.
NYSE
SCHEDULE: Vanguard Discloses 5.22% Stake in Macy's
Vanguard Portfolio Management has reported beneficial ownership of 13,785,524 shares of Macy's Inc. common stock, representing 5.22% of the class, as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Macy's Inc. common stock following an internal realignment.
NYSE
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a beneficial ownership of 3.6% in Macy's Inc. common stock as of September 30, 2025.